NASDAQ · Medical Devices · USD

enVVeno Medical Corporation (NVNO) Stock Analysis

enVVeno Medical Corporation (NVNO) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

NVNO

$7.33

−$0.37 (−4.81%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NVNO with… →

NVNO Key Statistics

As of Oct 21, 2026

Trading

Open: $8.27
Previous Close: $7.70
Day's Range: 7.21–8.27
52-Week Range: 7.01–27.27
Volume: 45.73K
Beta: 1.29

Valuation

Market Cap: $5.09M
P/E Ratio: unprofitable
EPS (ttm): −24.99

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): −$19.47M
Shares Outstanding: 694.83K
1-Year Return: −71.23%

Dividend and dates

Avg Volume: 25.24K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NVNO closed at $7.33, −71.23% over 1 year.

enVVeno Medical Corporation (NVNO) has a market capitalization of $5.09M.

In fiscal 2025, NVNO reported revenue of $0.00.

NVNO Stock Return by Calendar Year

enVVeno Medical Corporation (NVNO) return since May 2018: what $10,000 became

1 year: $10,000 $2,877; −71.23%
5 years: $10,000 $215; −97.85%
Since May 2018: $10,000 $16; −99.84%

If you had invested $10,000 in enVVeno Medical Corporation (NVNO) at the close on May 31, 2018, the earliest close on record here, it would have been worth $16 at the close on October 21, 2026: −99.84% in total, −53.57% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+0.78%−89.37%−34.76%

2018*20192020202120222023202420252026*

Year	Return
2026 (partial year)	−34.76%
2025	−89.37%
2024	−41.25%
2023	+0.78%
2022	−22.61%
2021	−23.82%
2020	−37.09%
2019	−62.71%
2018 (partial year)	−71.85%

As of October 21, 2026.

NVNO Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$0.00	−$19.47M	—
2024	$0.00	−$21.82M	—
2023	$0.00	−$23.52M	—
2022	$0.00	−$24.67M	—

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$0.00	—	−$20.90M	−$19.47M	—
2024	$0.00	—	−$23.83M	−$21.82M	—
2023	$0.00	—	−$25.24M	−$23.52M	—
2022	$0.00	—	−$24.93M	−$24.67M	—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values enVVeno Medical Corporation (NVNO) at $5.09M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 33.

NVNO last closed at $7.33 on October 21, 2026. That is −$0.37 (−4.81%) against the previous close. Over the past 52 weeks the price has ranged from $7.01 to $27.27. The latest close sits 4.56% above that 52-week low.

Financial Health

In fiscal 2025, enVVeno Medical Corporation reported revenue of $0.00. The same year closed with a net loss of $19.47M. Trailing earnings per share are −24.99.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The trailing one-year total return is −71.23%. Across 5 years the annualized return works out at −53.60%. Beta against the wider market is reported at 1.29. Annualized volatility over the trailing 8 years is 92.61%.

Growth & Income

No dividend is on file for NVNO.

The strongest complete calendar year on file is 2023 at +0.78%; the weakest is 2025 at −89.37%. Of the 7 complete calendar years on file, 1 finished higher. 2026 is still running; the total return is −34.76% year to date.

Peer Comparison

enVVeno Medical Corporation (NVNO) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
enVVeno Medical Corporation	NVNO	$5.09M	—
Abbott Laboratories	ABT	$173.92B	32.4
Medtronic plc.	MDT	$119.00B	22.9
Stryker Corporation	SYK	$114.15B	30.8

The Medical Devices industry average P/E ratio is 27.1x. enVVeno Medical Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

MDT

Medtronic plc.

$119.00B

SYK

Stryker Corporation

$114.15B

BSX

Boston Scientific Corporation

$64.33B

Edwards Lifesciences Corporation

$50.95B

GEHC

GE HealthCare Technologies Inc.

$31.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About enVVeno Medical Corporation

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Visit website →